Open company graph database — free web & API
Login

Towns Co., Ltd.

株式会社タウンズ
Ticker
Listed market
TYO
Country
Japan
Employees (consolidated)
360
Related companies
9
§01

Basic information

BASIC
Head office
761-1 Kami-shima, Izu-no-kuni City, Shizuoka Prefecture, 410-2325, Japan
Chief executive
Masaki Nonaka
Capital
397,000,000  (3 100 million)
Employees (non-consolidated)
271 people
Employees (consolidated)
360 people
Start date
1987-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

6
Contract ResearchDevelopment, manufacturing, and sales of in vitro diagnostic pharmaceuticalsDevelopment, manufacturing, and sales of research reagentsDevelopment, manufacturing, and sales of medical analytical instrumentsDevelopment, manufacturing, and sales of industrial measurement instrumentsDevelopment, manufacturing, and sales of medical devices
§04

Related companies

9 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
TAUNS Laboratories, Inc.
Group
Clearvo Technologies Inc.
Group
EMC Healthcare Inc.
Group
ElectraDX, Inc.
Group
Mizuho Bank, Ltd.
Bank
Resona Bank Co., Ltd.
Bank
Mitsubishi UFJ Bank Ltd.
Bank
Japan Federation of Co-operative Central Bank
Bank
Shizuoka Bank
Bank
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

40 EVENTS

Founded in Numazu City, Shizuoka Prefecture, to conduct research and development of in vitro diagnostic pharmaceuticals, research reagents, and various analytical reagents, as well as development of related systems.Sources

Established a Tokyo branch and commenced sales.Sources

Built a new headquarters building in Kozu, Numazu City, Shizuoka Prefecture.Sources

Constructed a diagnostic drug factory, "Numazu Factory", in Kozu, Numazu City, Shizuoka Prefecture.Sources

Divested the development division to BL Corporation.Sources

Obtained a patent for the platinum-gold colloid method.Sources

Built a new headquarters building in Futaba-cho, Numazu City, Shizuoka Prefecture.Sources

Patent obtained for platinum-gold colloid manufacturing method. New headquarters building constructed in Futaba Town, Numazu City, Shizuoka Prefecture.Sources

Manufactured and sold the diagnostic kits "Capilia® O157" for E. coli O157 infection and "Capilia® VT" for enterohemorrhagic E. coli infection.Sources

Launched the world's first rapid diagnostic kit "ImunoEase® Adeno" using platinum-gold colloid for adenovirus infection.Sources

Launched the rapid diagnostic kit "ImunoEase® Flu" for influenza virus infection.Sources

Manufactured and sold diagnostic kits for E. coli O157 infection, "Capilia® O157", and for enterohemorrhagic E. coli infection, "Capilia® VT". Launched the world's first rapid diagnostic kit for adenovirus infection using platinum-gold colloid, "ImunoAce® Adeno". Launched rapid diagnostic kit for influenza virus infection, "ImunoAce® Flu".Sources

Launched the research reagent "LineJudge® FluA/pdm".Sources

Launched the diagnostic kit "Capilia® MAC Antibody ELISA" for pulmonary MAC disease.Sources

Established the "Kami-shima Factory" in Kami-shima, Izu-no-kuni City, Shizuoka Prefecture.Sources

Launched the diagnostic kit "Capilia® TB-Neo" for tuberculosis.Sources

Headquarters relocated to Kami-shima, Izunokuni City, Shizuoka Prefecture.Sources

ISO 13485 certification obtained.Sources

Rapid diagnostic kit for RSV infection, "ImunoAce® RSV Neo", launched.Sources

Established the "Kamisama Factory" in Kamishima, Izunokuni City, Shizuoka Prefecture. Launched the tuberculosis diagnostic kit "Capilia® TB-Neo". Moved headquarters to Kamishima, Izunokuni City, Shizuoka Prefecture. Obtained ISO 13485 certification. Launched the rapid diagnostic kit for RSV infection "ImunoAce® RSV Neo".Sources

Rapid diagnostic kit for Group A streptococcal infection, "ImunoAce® Strep A", launched.Sources

Rapid diagnostic kit for Mycoplasma infection, "ImunoAce® Mycoplasma", launched.Sources

Rapid diagnostic kit for human metapneumovirus infection, "ImunoAce® hMPV", launched.Sources

Merged with B.L. Co., Ltd. and integrated the development division.Sources

Launched the rapid diagnostic kit for human metapneumovirus infection "ImunoAce® hMPV". Merged with B.L. Co., Ltd. and integrated the development department.Sources

Rapid diagnostic kit for influenza virus and/or RSV infection, "ImunoAce® Flu/RSV", launched.Sources

Established a Shimizu Town office and R&D center in Shimizu Town, Suruga District, Shizuoka Prefecture.Sources

Rapid diagnostic kit for Group A streptococcal infection, "ImunoAce® Strep A Neo", launched.Sources

Rapid diagnostic kit for SARS-CoV-2 infection, "ImunoAce® SARS-CoV-2", launched.Sources

Rapid diagnostic kit for norovirus infection, "ImunoAce® Norovirus", launched.Sources

Launched the rapid diagnostic kit for influenza virus and/or RSV infection "ImunoAce® Flu/RSV". Established the Shimizu Office and R&D Center in Shimizu Town, Sunzu District, Shizuoka Prefecture. Launched the rapid diagnostic kit for group A streptococcal infection "ImunoAce® Strep A Neo". Launched the rapid diagnostic kit for SARS-CoV-2 infection "ImunoAce® SARS-CoV-2". Launched the rapid diagnostic kit for norovirus infection "ImunoAce® Norovirus".Sources

Rapid diagnostic kit for SARS-CoV-2 infection, "ImunoAce® SARS-CoV-2 II", launched.Sources

Launched the rapid diagnostic kit for SARS-CoV-2 infection "ImunoAce® SARS-CoV-2 II".Sources

Rapid diagnostic kit for SARS-CoV-2 infection, "ImunoAce® SARS-CoV-2 Saliva", launched.Sources

Rapid diagnostic kit for SARS-CoV-2 or influenza virus infection, "ImunoAce® SARS-CoV-2/Flu", launched.Sources

Launched the rapid diagnostic kit for SARS-CoV-2 infection "ImunoAce® SARS-CoV-2 Saliva". Launched the rapid diagnostic kit for SARS-CoV-2 or influenza virus infection "ImunoAce® SARS-CoV-2/Flu".Sources

Developed the zinc kit "Accuried Zinc" and the universal spectrophotometer "Accuried" (sold by Nobel Pharma Co., Ltd.).Sources

Rapid diagnostic kit for SARS-CoV-2 infection, "ImunoAce® SARS-CoV-2 III", launched.Sources

Listed shares on the Tokyo Stock Exchange Standard Market.Sources

Launched the rapid diagnostic kit for SARS-CoV-2 infection "ImunoAce® SARS-CoV-2 III". Listed shares on the Tokyo Stock Exchange Standard Market.Sources

§07

News

15 ARTICLES

NoticeSources

Notice

Notice of Website RestorationSources

The website, which was temporarily suspended for security measures, has completed the necessary actions and will resume public access from October 30, 2026. We apologize for any inconvenience and concern caused to users.

News ReleaseSources

News Release

Notice of Web Server MaintenanceSources

Town Co., Ltd. will perform web server maintenance on July 28, 2026, during which access to the website may be temporarily difficult.

Web Server Maintenance NoticeSources

Town Co., Ltd. will conduct web server maintenance on November 19, 2025, during which access to the website may be temporarily difficult.

Important NoticeSources

Important Notice

How to Use the New Coronavirus Antigen Test KitSources

Town's Co., Ltd. provides guidance on how to use the new coronavirus antigen qualitative test kits "ImmunoAce® SARS-CoV-2 Ⅱ" and "ImmunoAce® SARS-CoV-2 Saliva".

Towns conducts blood donation activity at headquartersSources

Towns Corporation held a blood donation event at its headquarters in Izu no Kuni City, Shizuoka Prefecture, and thoroughly implemented infection prevention measures.

Town's Inc. 8th Term Financial Announcement (FY 2023 June Term)Sources

Town's Inc. announced the financial results for the 8th term (FY 2023 June Term) on September 29, 2023.

Notice of change in how to open email attachmentsSources

Townes Corporation has introduced 'HENNGE ONE' to enhance security, and is informing that the method of opening email attachments has been changed.

§08

Public records

GOV
National Tax Agency basic information4010001175101
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社タウンズ
Trade name (kana)
タウンズ
Name in English
Corporation type
301
Address
〒410-2325 静岡県伊豆の国市神島761番1
Postal code
4102325
Prefecture code
22
City code
225
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2016-04-22
Update date
2021-07-15
Change date
2021-07-14
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
11
Correction type
0
Trade name image ID
Address image ID
Sequence number
3399740
METI gBizINFO4010001175101
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
4010001175101
Trade name
株式会社タウンズ
Trade name (kana)
タウンズ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
静岡県伊豆の国市神島761番1
Postal code
4102325
Prefecture
静岡県
Prefecture code
22
City or district
伊豆の国市
City code
225
Street address
神島761番1
Organisation type
301
Processing type
11
Correction type
0
Status
Representative
代表取締役社長  野中 雅貴
Capital
400750000
Employees
262
Employees (male)
Employees (female)
Business summary
Website URL
https://www.tauns.co.jp/recruit/evaluation/
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2021-07-15
Key information
4010001175101
§09

Sources & updates

SOURCES
↑